Resecting more than just the tuber may help prolong seizure freedom in patients with TSC.
News
Both the 100 and 200 mg/d dose were found to be safe and effective in POS patients 16 years and older.
EpiWatch tracks seizures in real time and evaluates patient awareness.
Patients in the MT group also experienced a reduction in depression, anxiety, and seizure frequency.
Despite some promising trials, research continues to be hindered by laws that limit access to marijuana.
3D printing technology is used to create a porous drug that disintegrates rapidly with just a sip of liquid.
The safety profile was very similar to trials in patients with partial-onset seizures.
Among the 18 patients diagnosed with NFLE, 67% reported satisfaction with seizure control and lack of adverse events.
The majority of patients had fewer seizures and a higher quality of life.
Researchers suggest that there may be a common mechanism between SUDEP and SIDS.
The NIH hopes the collaborative, multi-specialty effort will help advance research.
Crashes less likely in subclinical epileptiform discharge and nonepileptic events than epilepsy, but disorders still dangerous, researchers warn.
The affected lot may contain empty capsules of Gabapentin.
The brains of children who undergo temporal lobe surgery for epilepsy seem to adapt and improve memory function.
The Sudden Death in the Young Registry will help researchers better understand the causes of and set research priorities for sudden unexpected death in epilepsy (SUDEP), heart disease.
Although ketogenic diets are often only used in children, the fat to protein/carb ratio plan is effective in adults
Responsive stimulation had no adverse effect on quality of life or mood in patients with intractable partial onset epilepsy.
Clobazam was safe and effective in reducing atonic seizures among patients with Lennox-Gestaut syndrome who participated in the CONTAIN trial.
Thalamic activity has value as a predictive marker of seizure onset laterality.
Low-dose fish oil reduced seizure frequency compared with placebo.
Upsher-Smith announced the launch of Qudexy XR (topiramate) extended-release capsules.
No improved efficacy, safety with lorazepam compared with diazepam.